1887

Abstract

Introduction. Pseudomonas aeruginosa has the ability to acquire plasmids and other mobile genetic elements that confer resistance to antibiotics. Bacterial genes encoding different β-lactamases (bla), such as metallo-β-lactamases (MBLs) and extended-spectrum β-lactamases (ESBL), can confer resistance to multiple classes of β-lactam antibiotics.

Case presentation. An 83 year old female was admitted in 2012 to the Peruvian Naval Hospital, Centro Médico Naval ‘Cirujano Mayor Santiago Távara’ (CEMENA), in Lima, Peru. A midstream urine sample was collected and sent to the local CEMENA laboratory for routine urine culture. P. aeruginosa was isolated and initial antibiotic susceptibility testing showed it to be sensitive to imipenem. The clinicians started a course of meropenem, but the patient did not improve. After 5 days, a second urine culture was performed and a P. aeruginosa was isolated again, but this time the strain showed resistance to imipenem. The treatment course was changed to fosfomycin and the patient improved. Phenotypic and molecular laboratory testing to characterize the antibiotic resistance were performed, demonstrating the presence of both MBL and ESBL genes.

Conclusion. To our knowledge, this is the first report of a P. aeruginosa XDR clinical isolate that co-expresses an MBL (VIM-2), OXA-1 beta-lactamase and the ESBL (GES-1) in Peru. It is also the first report of a VIM carbapenemase in Peru.

  • This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Loading

Article metrics loading...

/content/journal/jmmcr/10.1099/jmmcr.0.005154
2018-06-21
2024-03-19
Loading full text...

Full text loading...

/deliver/fulltext/jmmcr/5/7/jmmcr005154.html?itemId=/content/journal/jmmcr/10.1099/jmmcr.0.005154&mimeType=html&fmt=ahah

References

  1. Tang PC, Lee CC, Li CW, Li MC, Ko WC et al. Time-to-positivity of blood culture: an independent prognostic factor of monomicrobial Pseudomonas aeruginosa bacteremia. J Microbiol Immunol Infect 2017; 50:486–493 [View Article][PubMed]
    [Google Scholar]
  2. Kang CI, Kim SH, Kim HB, Park SW, Choe YJ et al. Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome. Clin Infect Dis 2003; 37:745–751 [View Article][PubMed]
    [Google Scholar]
  3. Hong DJ, Bae IK, Jang IH, Jeong SH, Kang HK et al. Epidemiology and characteristics of metallo-β-lactamase-producing Pseudomonas aeruginosa. Infect Chemother 2015; 47:81–97 [View Article][PubMed]
    [Google Scholar]
  4. Cornaglia G, Giamarellou H, Rossolini GM. Metallo-β-lactamases: a last frontier for β-lactams?. Lancet Infect Dis 2011; 11:381–393 [View Article][PubMed]
    [Google Scholar]
  5. Clinical and Laboratory Standards Institute Clinical and Laboratory Standards Institute: [Document] Wayne, PA: Clinical and Laboratory Standards Institute; 2013
    [Google Scholar]
  6. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012; 18:268–281 [View Article][PubMed]
    [Google Scholar]
  7. Pasteran F, Veliz O, Rapoport M, Guerriero L, Corso A. Sensitive and specific modified Hodge test for KPC and metallo-β- lactamase detection in Pseudomonas aeruginosa by use of a novel indicator strain, Klebsiella pneumoniae ATCC 700603. J Clin Microbiol 2011; 49:4301–4303 [View Article][PubMed]
    [Google Scholar]
  8. Radice M, Marín M, Giovanakis M, Vay C, Almuzara M et al. Antimicrobial susceptibility testing in clinically relevant non-fermenting Gram-negative bacilli: recommendations from the Antimicrobial Agents Subcommittee of the Sociedad Argentina de Bacteriología, Micología y Parasitología Clínicas, Asociación Argentina de Microbiología. Rev Argent Microbiol 2011; 43:136–153 [View Article][PubMed]
    [Google Scholar]
  9. Pellegrino FL, Netto-dos Santos KR, Riley LW, Moreira BM. BlaGES carrying Pseudomonas aeruginosa isolates from a public hospital in Rio de Janeiro, Brazil. Braz J Infect Dis 2006; 10:251–253 [View Article][PubMed]
    [Google Scholar]
  10. Ingold AJ, Castro M, Nabón A, Borthagaray G, Márquez C. VIM-2 metallo-β-lactamase gene detection in a class 1 integron associated to blaCTX-M-2 in a Pseudomonas aeruginosa clinical isolate in Uruguay: first communication. Rev Argent Microbiol 2011; 43:198–202 [View Article][PubMed]
    [Google Scholar]
  11. Sardelic S, Bedenic B, Colinon-Dupuich C, Orhanovic S, Bosnjak Z et al. Infrequent finding of metallo-β-lactamase VIM-2 in carbapenem-resistant Pseudomonas aeruginosa strains from Croatia. Antimicrob Agents Chemother 2012; 56:2746–2749 [View Article][PubMed]
    [Google Scholar]
  12. Polotto M, Casella T, de Lucca Oliveira MG, Rúbio FG, Nogueira ML et al. Detection of P. aeruginosa harboring blaCTX-M-2, blaGES-1 and blaGES-5, blaIMP-1 and blaSPM-1 causing infections in Brazilian tertiary-care hospital. BMC Infect Dis 2012; 12:176 [View Article][PubMed]
    [Google Scholar]
  13. Pasteran F, Faccone D, Petroni A, Rapoport M, Galas M et al. Novel variant blaVIM-11 of the metallo-β-lactamase blaVIM family in a GES-1 extended-spectrum-β-lactamase-producing Pseudomonas aeruginosa clinical isolate in Argentina. Antimicrob Agents Chemother 2005; 49:474–475 [View Article][PubMed]
    [Google Scholar]
  14. Bellais S, Mimoz O, Léotard S, Jacolot A, Petitjean O et al. Efficacy of β-lactams for treating experimentally induced pneumonia due to a carbapenem-hydrolyzing metallo-β-lactamase-producing strain of Pseudomonas aeruginosa. Antimicrob Agents Chemother 2002; 46:2032–2034 [View Article][PubMed]
    [Google Scholar]
  15. Monogue ML, Abbo LM, Rosa R, Camargo JF, Martinez O et al. In vitro discordance with in vivo activity: humanized exposures of ceftazidime-avibactam, aztreonam, and tigecycline alone and in combination against New Delhi metallo-β-lactamase-producing Klebsiella pneumoniae in a murine lung infection model. Antimicrob Agents Chemother 2017; 61:e00486-17 [View Article][PubMed]
    [Google Scholar]
  16. Deplano A, Rodriguez-Villalobos H, Glupczynski Y, Bogaerts P, Allemeersch D et al. Emergence and dissemination of multidrug resistant clones of Pseudomonas aeruginosa producing VIM-2 metallo-β-lactamase in Belgium. Euro Surveill 2007; 12:E070118.2 [View Article][PubMed]
    [Google Scholar]
  17. Kahan FM, Kahan JS, Cassidy PJ, Kropp H. The mechanism of action of fosfomycin (phosphonomycin). Ann N Y Acad Sci 1974; 235:364–386 [View Article][PubMed]
    [Google Scholar]
  18. Neuner EA, Sekeres J, Hall GS, van Duin D. Experience with fosfomycin for treatment of urinary tract infections due to multidrug-resistant organisms. Antimicrob Agents Chemother 2012; 56:5744–5748 [View Article][PubMed]
    [Google Scholar]
  19. Falagas ME, Kastoris AC, Karageorgopoulos DE, Rafailidis PI. Fosfomycin for the treatment of infections caused by multidrug-resistant non-fermenting Gram-negative bacilli: a systematic review of microbiological, animal and clinical studies. Int J Antimicrob Agents 2009; 34:111–120 [View Article][PubMed]
    [Google Scholar]
  20. Walsh CC, McIntosh MP, Peleg AY, Kirkpatrick CM, Bergen PJ. In vitro pharmacodynamics of fosfomycin against clinical isolates of Pseudomonas aeruginosa. J Antimicrob Chemother 2015; 70:3042–3050 [View Article][PubMed]
    [Google Scholar]
  21. Pasteran F, Mendez T, Guerriero L, Rapoport M, Corso A. Sensitive screening tests for suspected class A carbapenemase production in species of Enterobacteriaceae. J Clin Microbiol 2009; 47:1631–1639 [View Article][PubMed]
    [Google Scholar]
  22. Erickson KE, Otoupal PB, Chatterjee A. Gene expression variability underlies adaptive resistance in phenotypically heterogeneous bacterial populations. ACS Infect Dis 2015; 1:555–567 [View Article][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmmcr/10.1099/jmmcr.0.005154
Loading
/content/journal/jmmcr/10.1099/jmmcr.0.005154
Loading

Data & Media loading...

Supplements

Supplementary File 1

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error